China’s Qiming Ventures leads $37m funding in AlphaBio Biopharma Visual from Alpha Biopharma's website. Mars Woo June 20, 2018 PremiumChinese venture capital firm Qiming Venture Partners took the lead in the $37-million first close of Shanghai-based biopharmaceutical firm Alpha Biopharma (AlphaBio)’s Series A financing. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in Should your colleagues be reading this article too? Contact us for corporate subscriptions at email@example.com.